Impact of Herpes Zoster and Postherpetic Neuralgia on the Quality of Life in China: A Prospective Study
Yong Liu,Hui Liu,Queqiao Bian,Shuhuan Zhang,Yanmin Guan
DOI: https://doi.org/10.2147/ccid.s471823
2024-08-27
Clinical Cosmetic and Investigational Dermatology
Abstract:Yong Liu, 1 Hui Liu, 2 Queqiao Bian, 1 Shuhuan Zhang, 1 Yanmin Guan 3 1 Department of Dermatology & STD, The Third Central Hospital of Tianjin; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases; Artificial Cell Engineering Technology Research Center; Tianjin Institute of Hepatobiliary Disease, Tianjin, People's Republic of China; 2 Tianjin Institute of Hepatobiliary Disease, The Third Central Hospital of Tianjin, Tianjin, People's Republic of China; 3 Department of Tuberculosis, Tianjin Haihe Hospital, Tianjin, People's Republic of China Correspondence: Yong Liu, Department of Dermatology & STD, The Third Central Hospital of Tianjin; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases; Artificial Cell Engineering Technology Research Center; Tianjin Institute of Hepatobiliary Disease, No. 83, Jintang Road, Hedong District, Tianjin, 300170, People's Republic of China, Email Background: Herpes zoster (HZ) and postherpetic neuralgia (PHN) significantly affect patients' quality of life (QoL). Cultural differences may lead to different patient-reported outcomes across countries. The current study aims to evaluate the detrimental impact of HZ and PHN on QoL in China. Methods: This prospective study was conducted from January 2020 to April 2023. We used the Zoster Brief Pain Inventory (ZBPI) and 5-level EuroQol-5 Dimension (EQ-5D-5L) questionnaire to assess the QoL of HZ and PHN patients. Patients were required to complete the questionnaires at 15, 30, 60, and 90 days after the onset of the HZ rash. Additional questionnaires were administered at 120, 150, and 180 days for those who developed PHN within three months of the rash's onset. Results: A cohort of 633 patients with a median age of 63 years were included in the study. The mean delay from the appearance of the initial HZ rash to the first medical consultation was 5.1 ± 2.8 days. Approximately 30% of the HZ patients (189/633) went on to develop PHN. For patients with HZ who did not progress to PHN, the ZBPI worst pain score and impaired QoL had nearly resolved by day 90 post-rash onset. Conversely, there was no significant improvement in the ZBPI worst pain score and QoL for those with PHN, even by day 180 post-rash onset. Conclusion: Both HZ and PHN significantly impaired patients' QoL. However, the impairment caused by PHN was more severe in both intensity and duration. Keywords: herpes zoster, pain, post-herpetic neuralgia, quality of life Herpes zoster (HZ), also known as shingles, is a viral reactivation of the varicella-zoster virus (VZV), which occurs when the immune system's cell-mediated defenses decline. 1 This condition is commonly marked by an agonizing rash with blisters following a single nerve's path, affecting one side of the body. 2 Individuals with a past case of chickenpox are susceptible to experiencing HZ. The global incidence of HZ is estimated at 3–5‰, 3 with a meta-analysis showing an incidence of 4.28/1000 person-years in China. 4 However, as individuals age, their immunity to VZV declines, leading to an increased risk of HZ. 5 A study from Miyun District of Beijing reported the incidence of HZ increased to 6.4–10.6/1000 person-years in people aged ≥ 50 years. 6 Patients with HZ have a high incidence of complications, especially for immunocompromised populations. 7 Postherpetic neuralgia (PHN), a debilitating and chronic neuropathic pain, is the most common complication of HZ. 8 It's defined as persistent HZ-related pain lasting at least three months after the rash appears. Like HZ, the incidence of PHN is higher in older individuals. 9 While estimates suggest 10–30% of HZ patients develop PHN, 10 different studies and definitions make this proportion vary. 11 Patients with HZ and PHN often experience various types of pain, including persistent or intermittent tingling, increased sensitivity to pain, burning pain, sharp pain, and pain triggered by touch. 12 This pain can last for months or even years. HZ and PHN significantly compromised the patients' health-related quality of life (QoL). 13 The pain can affect daily activities, social interactions, mental health, and even the ability to maintain independence. Moreover, PHN had a much more significant impact than HZ in the above dimensions. 6 While studies from other countries have shown a negative relationship between HZ/PHN and QoL, 14–17 cultural differences may influence patient-reported outcomes. 18,19 This research seeks to evaluate the effects of HZ and PHN on QoL in China, considering the expected -Abstract Truncated-
dermatology